124 related articles for article (PubMed ID: 24549736)
1. Determination of atypical nonlinear plasma−protein-binding behavior of tigecycline using an in vitro microdialysis technique.
Mukker JK; Singh RP; Derendorf H
J Pharm Sci; 2014 Mar; 103(3):1013-9. PubMed ID: 24549736
[TBL] [Abstract][Full Text] [Related]
2. Role of Divalent Metal Ions in Atypical Nonlinear Plasma Protein Binding Behavior of Tigecycline.
Singh RSP; Mukker JK; Deitchman AN; Drescher SK; Derendorf H
J Pharm Sci; 2016 Nov; 105(11):3409-3414. PubMed ID: 27616672
[TBL] [Abstract][Full Text] [Related]
3. Impact of Experimental Variables on the Protein Binding of Tigecycline in Human Plasma as Determined by Ultrafiltration.
Dorn C; Kratzer A; Liebchen U; Schleibinger M; Murschhauser A; Schlossmann J; Kees F; Simon P; Kees MG
J Pharm Sci; 2018 Feb; 107(2):739-744. PubMed ID: 28927988
[TBL] [Abstract][Full Text] [Related]
4. A novel antibiotic bone assay by liquid chromatography/tandem mass spectrometry for quantitation of tigecycline in rat bone.
Ji AJ; Saunders JP; Wadgaonkar ND; Petersen PJ; O'Leary K; McWilliams WE; Amorusi P; Leal M; Fluhler EN
J Pharm Biomed Anal; 2007 Aug; 44(4):970-9. PubMed ID: 17537611
[TBL] [Abstract][Full Text] [Related]
5. The complexity of minocycline serum protein binding.
Zhou J; Tran BT; Tam VH
J Antimicrob Chemother; 2017 Jun; 72(6):1632-1634. PubMed ID: 28333250
[TBL] [Abstract][Full Text] [Related]
6. A sensitive human bone assay for quantitation of tigecycline using LC/MS/MS.
Ji AJ; Saunders JP; Amorusi P; Wadgaonkar ND; O'Leary K; Leal M; Dukart G; Marshall B; Fluhler EN
J Pharm Biomed Anal; 2008 Nov; 48(3):866-75. PubMed ID: 18692977
[TBL] [Abstract][Full Text] [Related]
7. Rapid turbidimetric assay to potency evaluation of tigecycline in lyophilized powder.
da Silva LM; Salgado HR
J Microbiol Methods; 2015 Mar; 110():49-53. PubMed ID: 25619746
[TBL] [Abstract][Full Text] [Related]
8. A need to revisit clinical breakpoints of tigecycline: effect of atypical non-linear plasma protein binding.
Singh RSP; Mukker JK; Drescher SK; Deitchman AN; Derendorf H
Int J Antimicrob Agents; 2017 Apr; 49(4):449-455. PubMed ID: 28237830
[TBL] [Abstract][Full Text] [Related]
9. Determination of tigecycline in human skin using a novel validated LC-MS/MS method.
Ji Ji A; Saunders JP; Amorusi P; Stein G; Wadgaonkar ND; O'Leary KP; Leal M; Fluhler EN
Bioanalysis; 2010 Jan; 2(1):81-94. PubMed ID: 21083122
[TBL] [Abstract][Full Text] [Related]
10. Determination of geniposide in adjuvant arthritis rat plasma by ultra-high performance liquid chromatography tandem mass spectrometry method and its application to oral bioavailability and plasma protein binding ability studies.
Chen J; Wu H; Xu GB; Dai MM; Hu SL; Sun LL; Wang W; Wang R; Li SP; Li GQ
J Pharm Biomed Anal; 2015 Apr; 108():122-8. PubMed ID: 25771205
[TBL] [Abstract][Full Text] [Related]
11. Determination of total and unbound concentrations of lopinavir in plasma using liquid chromatography-tandem mass spectrometry and ultrafiltration methods.
Illamola SM; Labat L; Benaboud S; Tubiana R; Warszawski J; Tréluyer JM; Hirt D
J Chromatogr B Analyt Technol Biomed Life Sci; 2014 Aug; 965():216-23. PubMed ID: 25049210
[TBL] [Abstract][Full Text] [Related]
12. Tissue penetration and pharmacokinetics of tigecycline in diabetic patients with chronic wound infections described by using in vivo microdialysis.
Bulik CC; Wiskirchen DE; Shepard A; Sutherland CA; Kuti JL; Nicolau DP
Antimicrob Agents Chemother; 2010 Dec; 54(12):5209-13. PubMed ID: 20921312
[TBL] [Abstract][Full Text] [Related]
13. Ultra performance liquid chromatography PDA method for determination of tigecycline in human plasma.
D'Avolio A; Peila E; Simiele M; Pensi D; Baietto L; Cusato J; Cinnirella G; De Rosa F; Di Perri G
Ther Drug Monit; 2013 Dec; 35(6):853-8. PubMed ID: 24067259
[TBL] [Abstract][Full Text] [Related]
14. Determination of unbound drug concentration and protein-drug binding fraction in plasma.
Liu Z; Li F; Huang Y
Biomed Chromatogr; 1999 Jun; 13(4):262-6. PubMed ID: 10416057
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics of tigecycline after single and multiple doses in healthy subjects.
Muralidharan G; Micalizzi M; Speth J; Raible D; Troy S
Antimicrob Agents Chemother; 2005 Jan; 49(1):220-9. PubMed ID: 15616299
[TBL] [Abstract][Full Text] [Related]
16. Effect of the anticoagulant ethylenediamine tetra-acetic acid (EDTA) on the estimation of pharmacokinetic parameters: A case study with tigecycline and ciprofloxacin.
Chen Q; Tung EC; Ciccotto SL; Strauss JR; Ortiga R; Ramsay KA; Tang W
Xenobiotica; 2008 Jan; 38(1):76-86. PubMed ID: 17963190
[TBL] [Abstract][Full Text] [Related]
17. [Rat in vitro plasma-binding percentage determination of sinomenine hydrochloride by using microdialysis method and ultrafiltration].
Zhang Y; Zhou L
Zhongguo Zhong Yao Za Zhi; 2010 Oct; 35(19):2616-9. PubMed ID: 21174777
[TBL] [Abstract][Full Text] [Related]
18. Functional, biophysical, and structural bases for antibacterial activity of tigecycline.
Olson MW; Ruzin A; Feyfant E; Rush TS; O'Connell J; Bradford PA
Antimicrob Agents Chemother; 2006 Jun; 50(6):2156-66. PubMed ID: 16723578
[TBL] [Abstract][Full Text] [Related]
19. Bioanalysis of therapeutic peptides: differentiating between total and anti-drug antibody bound drug using liquid chromatography-tandem mass spectrometry quantitation.
Heinig K; Wirz T; Schick E; Guenzi A
J Chromatogr A; 2013 Nov; 1316():69-77. PubMed ID: 24119751
[TBL] [Abstract][Full Text] [Related]
20. Correlation of in vitro and in vivo plasma protein binding using ultracentrifugation and UPLC-tandem mass spectrometry.
Srikanth CH; Chaira T; Sampathi S; V B S; Bambal RB
Analyst; 2013 Oct; 138(20):6106-16. PubMed ID: 23964358
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
